Standardized Sequence and Structure Analysis of Antibody Using IMGT®

  • François Ehrenmann
  • Patrice Duroux
  • Véronique Giudicelli
  • Marie-Paule LefrancEmail author
Part of the Springer Protocols Handbooks book series (SPH)


Standardized sequence and structure analysis of antibody using IMGT®, the international ImMunoGeneTics information system® (, allows to bridge, for the first time, the gap between antibody sequences and three-dimensional (3D) structures. This is achieved through the IMGT Scientific chart rules, based on IMGT-ONTOLOGY. IMGT® is the international reference for immunogenetics and immunoinformatics, and its standards (IMGT nomenclature and labels and IMGT unique numbering) are particularly useful for antibody humanization and evaluation of immunogenicity. In IMGT®, the antibody analysis from nucleotide sequence to 2D structure is supported by the widely used IMGT/V-QUEST system and the integrated IMGT/JunctionAnalysis software. The IMGT® approach from amino acid sequence to 3D structure is supported by the IMGT/DomainDisplay, IMGT/DomainGapAlign and IMGT/Collier-de-Perles tools, by some important features of IMGT/2Dstructure-DB, for antibodies for which 3D structures are not yet available (INN entries) and IMGT/3Dstructure-DB and associated tools, for crystallized antibodies (Contact analysis, IMGT/StructuralQuery, IMGT/DomainSuperimpose).


Versus Domain Contact Analysis Synthesis View Result Display International Nonproprietary Name 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



We thank Chantal Ginestoux for the figures. We are very grateful to Gérard Lefranc for helpful discussions and to the IMGT® team for its expertise and constant motivation. IMGT® is a registered trademark of CNRS. IMGT® is member of the International Medical Informatics Association (IMIA). IMGT® was funded in part by the BIOMED1 (BIOCT930038), Biotechnology BIOTECH2 (BIO4CT960037) and 5th PCRDT Quality of Life and Management of Living Resources programmes (QLG2-2000-01287) programmes of the European Union (EU). IMGT® is currently supported by the Centre National de la Recherche Scientifique (CNRS), the Ministère de l'Enseignement Supérieur et de la Recherche (MESR) (Université Montpellier 2 Plan Pluri-Formation, Institut Universitaire de France), the GIS IBiSA, the Région Languedoc-Roussillon (Grand Plateau Technique pour la Recherche Région (GPTR) Languedoc-Roussillon), the Agence Nationale de la recherche ANR (BIOSYS06_135457, FLAVORES) and the EU 6th PCRDT ImmunoGrid (FP6 IST-028069).


  1. Brochet X, Lefranc M-P, Giudicelli V (2008) IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. Nucl Acids Res 36:W503–W508PubMedCrossRefGoogle Scholar
  2. Duroux P, Kaas Q, Brochet X, Lane J, Ginestoux C, Lefranc M-P, Giudicelli V (2008) IMGT-Kaleidoscope, the formal IMGT-ONTOLOGY paradigm. Biochimie 90:570–583PubMedCrossRefGoogle Scholar
  3. Elemento O, Lefranc M-P (2003) IMGT/PhyloGene: an on-line tool for comparative analysis of immunoglobulin and T cell receptor genes. Dev Comp Immunol 27:763–779PubMedCrossRefGoogle Scholar
  4. Ghia P, Stamatopoulos K, Belessi C, Moreno C, Stilgenbauer S, Stevenson F, David F, Rosenquist R (2007) ERIC recommendations on IGHV gene mutational status analysis in chronic lymphocytic leukaemia. Leukaemia 21:1–3CrossRefGoogle Scholar
  5. Giudicelli V, Lefranc M-P (1999) Ontology for immunogenetics: IMGT-ONTOLOGY. Bioinformatics 15:1047–1054PubMedCrossRefGoogle Scholar
  6. Giudicelli V, Lefranc M-P (2005) Interactive IMGT on-line tools for the analysis of immunoglobulin and T cell receptor repertoires. In: Veskler BA (ed) New research on immunology. Nova Science, pp 77–105Google Scholar
  7. Giudicelli V, Lefranc M-P (2008) IMGT® standardized analysis of immunoglobulin rearranged sequences. In: Ghia P, Rosenquist R, Davi F (eds), Immunoglobulin gene analysis in chronic lymphocytic leukemia, Chap. 2. Wolters Kluwer Health, Italy, pp 33–52Google Scholar
  8. Giudicelli V, Protat C, Lefranc M-P (2003) The IMGT strategy for the automatic annotation of IG and TR cDNA sequences: IMGT/Automat. In: Proceedings of the European conference on computational biology (ECCB 2003), INRIA (DISC/Spid), Paris, DKB-31, pp103–104Google Scholar
  9. Giudicelli V, Chaume D, Lefranc M-P (2005a) IMGT/GENE-DB: a comprehensive database for human and mouse immunoglobulin and T cell receptor genes. Nucl Acids Res 33:D256–D261PubMedCrossRefGoogle Scholar
  10. Giudicelli V, Chaume D, Jabado-Michaloud J, Lefranc M-P (2005b) Immunogenetics sequence annotation: the strategy of IMGT based on IMGT-ONTOLOGY. Stud Health Technol Inform 116:3–8PubMedGoogle Scholar
  11. Giudicelli V, Duroux P, Ginestoux C, Folch G, Jabado-Michaloud J, Chaume D, Lefranc M-P (2006) IMGT/LIGM-DB, the IMGT® comprehensive database of immunoglobulin and T cell receptor nucleotide sequences. Nucl Acids Res 34:D781–D784PubMedCrossRefGoogle Scholar
  12. Kaas Q, Lefranc M-P (2007) IMGT Colliers de Perles: standardized sequence–structure representations of the IgSF and MhcSF superfamily domains. Curr Bioinformat 2:21–30CrossRefGoogle Scholar
  13. Kaas Q, Ruiz M, Lefranc M-P (2004) IMGT/3Dstructure-DB and IMGT/StructuralQuery, a database and a tool for immunoglobulin. T cell receptor and MHC structural data. Nucl Acids Res 32:D208–D210PubMedCrossRefGoogle Scholar
  14. Kaas Q, Ehrenmann F, Lefranc M-P (2007) IG, TR and IgSf, MHC and MhcSF: what do we learn from the IMGT Colliers de Perles? Brief Funct Genomic Proteomic 6:253–264PubMedCrossRefGoogle Scholar
  15. Lefranc M-P (1997) Unique database numbering system for immunogenetic analysis. Immunol Today 18:509PubMedCrossRefGoogle Scholar
  16. Lefranc M-P (1999) The IMGT unique numbering for immunoglobulins, T cell receptors and Ig-like domains. The Immunologist 7:132–136Google Scholar
  17. Lefranc M-P (2000) Nomenclature of the human immunoglobulin genes. In: Coligan JE, Bierer BE, Margulies DE, Shevach EM, Strober W (eds) Current protocols in immunology. Wiley, Hoboken NJ, pp A.1P.1–A.1P.37Google Scholar
  18. Lefranc M-P (2000) Nomenclature of the human T cell receptor genes. In: Coligan JE, Bierer BE, Margulies DE, Shevach EM, Strober W (eds) Current protocols in immunology. Wiley, Hoboken, NJ, pp A.1O.1–A.1O.23Google Scholar
  19. Lefranc M-P (2004) IMGT, the international ImMunoGenetics information system®. In: Lo BKC (ed) Antibody engineering methods and protocols, 2nd edn. Methods in molecular biology, vol 248. Humana Press, Totowa, NJ, USA, pp 27–49Google Scholar
  20. Lefranc M-P (2007) WHO–IUIS nomenclature subcommittee for immunoglobulins and T cell receptors report. Immunogenetics 59:899–902PubMedCrossRefGoogle Scholar
  21. Lefranc M-P (2008) WHO–IUIS nomenclature subcommittee for immunoglobulins and T cell receptors report August 2007, 13th international congress of immunology, Rio de Janeiro. Brazil Dev Comp Immunol 32:461–463CrossRefGoogle Scholar
  22. Lefranc M-P, Lefranc G (2001a) The immunoglobulin factsbook. Academic Press, London, UK, pp 1–458Google Scholar
  23. Lefranc M-P, Lefranc G (2001b) The T cell receptor factsbook. Academic Press, London, UK, pp 1–398Google Scholar
  24. Lefranc M-P, Pommié C, Ruiz M, Giudicelli V, Foulquier E, Truong L, Thouvenin-Contet V, Lefranc G (2003) IMGT unique numbering for immunoglobulin and T cell receptor variable domains and Ig superfamily V-like domains. Dev Comp Immunol 27:55–77PubMedCrossRefGoogle Scholar
  25. Lefranc M-P, Giudicelli V, Ginestoux C, Bosc N, Folch G, Guiraudou D, Jabado-Michaloud J, Magris S, Scaviner D, Thouvenin V, Combres K, Girod D, Jeanjean S, Protat C, Yousfi Monod M, Duprat E, Kaas Q, Pommié C, Chaume D, Lefranc G (2004) IMGT-ONTOLOGY for immunogenetics and immunoinformatics. In Silico Biol 4:17–29PubMedGoogle Scholar
  26. Lefranc M-P, Clément O, Kaas Q, Duprat E, Chastellan P, Coelho I, Combres K, Ginestoux C, Giudicelli V, Chaume D, Lefranc G (2005a) IMGT-choreography for immunogenetics and immunoinformatics. In Silico Biol 5:45–60PubMedGoogle Scholar
  27. Lefranc M-P, Pommié C, Kaas Q, Duprat E, Bosc N, Guiraudou D, Jean C, Ruiz M, Da Piedade I, Rouard M, Foulquier E, Thouvenin V, Lefranc G (2005b) IMGT unique numbering for immunoglobulin and T cell receptor constant domains and Ig superfamily C-like domains. Dev Comp Immunol 29:185–203PubMedCrossRefGoogle Scholar
  28. Lefranc M-P, Duprat E, Kaas Q, Tranne M, Thiriot A, Lefranc G (2005c) IMGT unique numbering for MHC groove G-DOMAIN and MHC superfamily (MhcSF) G-LIKE-DOMAIN. Dev Comp Immunol 29:917–938PubMedCrossRefGoogle Scholar
  29. Lefranc M-P, Giudicelli V, Regnier L, Duroux P (2008) IMGT®, a system and an ontology that bridge biological and computational spheres in bioinformatics. Brief Bioinform 9:263–275PubMedCrossRefGoogle Scholar
  30. Lefranc M-P, Giudicelli V, Ginestoux C, Jabado-Michaloud J, Folch G, Bellahcene F, Wu Y, Gemrot E, Brochet X, Lane J, Regnier L, Ehrenmann F, Lefranc G, Duroux P (2009) IMGT®, the international ImMunoGeneTics information system®. Nucl Acids Res 37:D1006–D1012PubMedCrossRefGoogle Scholar
  31. Magdelaine-Beuzelin C, Kaas Q, Wehbi V, Ohresser M, Jefferis R, Lefranc M-P, Watier H (2007) Structure–function relationships of the variable domains of monoclonal antibodies approved for cancer treatment. Crit Rev Oncol Hematol 64:210–225PubMedCrossRefGoogle Scholar
  32. Maglott D, Ostell J, Pruitt KD, Tatusova T (2007) Entrez Gene: gene-centered information at NCBI. Nucl Acids Res 35:D26–D31PubMedCrossRefGoogle Scholar
  33. Pelat T, Bedouelle H, Rees AR, Crennell SJ, Lefranc M-P, Thullier P (2008) Germline humanization of a non-human primate antibody that neutralizes the anthrax toxin, by in vitro and in silico engineering. J Mol Biol 2008(384):1400–1407CrossRefGoogle Scholar
  34. Pommié C, Levadoux S, Sabatier R, Lefranc M-P (2004) IMGT standardized criteria for statistical analysis of immunoglobulin V-REGION amino acid properties. J Mol Recognit 17:17–32PubMedCrossRefGoogle Scholar
  35. Ruiz M, Lefranc M-P (2002) IMGT gene identification and Colliers de Perles of human immunoglobulins with known 3D structures. Immunogenetics 53:857–883PubMedCrossRefGoogle Scholar
  36. Stamatopoulos K, Belessi C, Moreno C, Boudjograh M, Guida G, Smilevska T, Belhoul L, Stella S, Stavroyianni N, Crespo M, Hadzidimitriou A, Sutton L, Bosch F, Laoutaris N, Anagnostopoulos A, Montserrat E, Fassas A, Dighiero G, Caligaris-Cappio F, Merle-Béral H, Ghia P, Davi F (2007) Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations. Blood 109:259–270PubMedCrossRefGoogle Scholar
  37. Wain HM, Bruford EA, Lovering RC, Lush MJ, Wright MW, Povey S (2002) Guidelines for human gene nomenclature. Genomics 79:464–470PubMedCrossRefGoogle Scholar
  38. Wilming LG, Gilbert JG, Howe K, Trevanion S, Hubbard T, Harrow JL (2008) The vertebrate genome annotation (Vega) database. Nucl Acids Res 36:D753–D760PubMedCrossRefGoogle Scholar
  39. Yousfi Monod M, Giudicelli V, Chaume D, Lefranc M-P (2004) IMGT/junctionanalysis: the first tool for the analysis of the immunoglobulin and T cell receptor complex V-J and V-D-J junctions. Bioinformatics 20:i379–i385PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2010

Authors and Affiliations

  • François Ehrenmann
    • 1
  • Patrice Duroux
    • 1
  • Véronique Giudicelli
    • 1
  • Marie-Paule Lefranc
    • 1
    Email author
  1. 1.IMGT®, the international ImMunoGeneTics Information System®, Laboratoire d’ImmunoGénétique Moléculaire LIGMUniversité Montpellier 2, Institut de Génétique HumaineMontpellier Cedex 5France

Personalised recommendations